Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

2C3 antibody inhibits tumor growth by 75%

Feb. 5, 2003

New phase I trial for VNP-40101M in solid tumors

Feb. 5, 2003

Pyrimidine-based tyrosine kinase inhibitors covered by Merck patent

Feb. 5, 2003

Arizona State U. researchers design new combretastatin A3 prodrugs

Feb. 5, 2003

Cytovia scientists design caspase activators and apoptosis inducers

Feb. 5, 2003

Enrollment completed in phase III Tarceva trial in refractory NSCLC

Feb. 4, 2003

Idec and Biogen to codevelop three Biogen oncology therapeutics

Feb. 4, 2003

New antitumor daunorubicin derivatives designed by Pharmacia

Feb. 4, 2003

Corixa and GSK form cancer vaccine collaboration

Feb. 3, 2003

ATN-161 enters the clinic

Feb. 3, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...